<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:g-core="http://base.google.com/ns/1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel rdf:about="http://www.prescriber.co.uk">
    <title>Prescriber news RSS Feed</title>
    <link>http://www.prescriber.co.uk</link>
    <description>Prescriber news RSS Feed</description>
    <items>
      <rdf:Seq>
        <rdf:li resource="http://www.prescriber.co.uk/details/news/1421875/DCCT_intensive_control_reduces_renal_risk.html" />
        <rdf:li resource="http://www.prescriber.co.uk/details/news/1421871/Prescribing_in_prisons.html" />
        <rdf:li resource="http://www.prescriber.co.uk/details/news/1421873/Citalopram_QT_risk.html" />
        <rdf:li resource="http://www.prescriber.co.uk/details/news/1421869/Call_to_action_to_combat_antibiotic_resistance.html" />
        <rdf:li resource="http://www.prescriber.co.uk/details/news/1421865/Insulin_glulisine_update.html" />
      </rdf:Seq>
    </items>
  </channel>
  <item rdf:about="http://www.prescriber.co.uk/details/news/1421875/DCCT_intensive_control_reduces_renal_risk.html">
    <title>DCCT: intensive control reduces renal risk</title>
    <link>http://www.prescriber.co.uk/details/news/1421875/DCCT_intensive_control_reduces_renal_risk.html</link>
    <description>The latest follow-up data from the Diabetes Control and Complications Trial (DCCT) shows that 6.5 years of intensive glycaemic control halves the risk of renal impairment 16 years later (NEJM 2011; doi: 10.1056/NEJMoa1111732).</description>
    <dc:date>2011-12-12T16:35:00Z</dc:date>
  </item>
  <item rdf:about="http://www.prescriber.co.uk/details/news/1421871/Prescribing_in_prisons.html">
    <title>Prescribing in prisons</title>
    <link>http://www.prescriber.co.uk/details/news/1421871/Prescribing_in_prisons.html</link>
    <description>The Royal College of General Practitioners Secure Environments Group has published a new guide to safer prescribing in prisons (www.rcgp.org.uk/pdf/Safer_Prescribing_in_Prison.pdf).</description>
    <dc:date>2011-12-12T16:34:00Z</dc:date>
  </item>
  <item rdf:about="http://www.prescriber.co.uk/details/news/1421873/Citalopram_QT_risk.html">
    <title>Citalopram QT risk</title>
    <link>http://www.prescriber.co.uk/details/news/1421873/Citalopram_QT_risk.html</link>
    <description>The maximum dose of citalopram has been limited to 40mg per day in a move to minimise the risk of a dose-dependent increase in the QT interval.</description>
    <dc:date>2011-12-12T16:34:00Z</dc:date>
  </item>
  <item rdf:about="http://www.prescriber.co.uk/details/news/1421869/Call_to_action_to_combat_antibiotic_resistance.html">
    <title>Call to action to combat antibiotic resistance</title>
    <link>http://www.prescriber.co.uk/details/news/1421869/Call_to_action_to_combat_antibiotic_resistance.html</link>
    <description>GPs should delay prescribing an antibiotic or when appropriate avoid it altogether, say health professionals attending a conference on antibiotic stewardship at the Royal Society of Medicine on 2 November.</description>
    <dc:date>2011-12-12T16:32:00Z</dc:date>
  </item>
  <item rdf:about="http://www.prescriber.co.uk/details/news/1421865/Insulin_glulisine_update.html">
    <title>Insulin glulisine update</title>
    <link>http://www.prescriber.co.uk/details/news/1421865/Insulin_glulisine_update.html</link>
    <description>Sanofi has published an update on the supply problems with the SoloStar and Apidra OptiSet pens and ClikStar cartridges containing insulin glulisine (Apidra).</description>
    <dc:date>2011-12-12T16:30:00Z</dc:date>
  </item>
</rdf:RDF>


